SecBot SecBot
SC 13G/A ·Filed Oct 30, 2026

CABA

Cabaletta Bio, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2d 2h ago SEC0002100119-26-001567
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future Vanguard 13G filings to track stake changes, but this filing alone is routine and non-actionable.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Vanguard Capital Management filed an amended Schedule 13G for Cabaletta Bio, reporting beneficial ownership of 8,187,183 shares (3.79% of common stock) as of September 30, 2026. This is a routine passive stake update by a large index/asset manager; no prior Vanguard 13G for CABA is in the provided context for comparison, so the direction of change is unknown. The filing has no material directional impact.

Key Financial Metrics

Stake
3.79%
Investor
Vanguard Capital Management LLC
Investor Type
mutual fund

Key Facts

  • Vanguard Capital Management reported 8,187,183 shares of Cabaletta Bio (3.79% of common stock) as of September 30, 2026.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
  • No prior Vanguard 13G for CABA is in the provided context, so the direction of change cannot be determined.

Financial Impact

No financial impact; stake is below 5% threshold and passive in nature.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0002100119-26-001567
Document: 0002100119-26-001567-index.html0002100119-26-001567
Document: 0002100119-26-001567.txt0002100119-26-001567
19 reports for CABA
Performance horizon
57% Hit rate @ T+5 4 of 7 directional calls Went positive at some point 5 of 7 best @ T+60▲ +31.59%May 4, 2026
Filters
Rows
Reports for CABA, sortable and filterable
TypeNow
Oct 30, 2026
2d ago
SC 13G/A
NEUTRAL ★ 2/10
$1.50awaiting T+5awaiting T+5$1.51 (+0.67%)
Oct 27, 2026
4d ago
SC 13G/A
NEUTRAL ★ 2/10
$1.52awaiting T+5awaiting T+5$1.51 (−0.66%)
Sep 14, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$2.91 $2.46▼ −15.46%▼ −15.57%$1.51 (−48.11%)
Aug 15, 2026
11w ago
Institutional Cluster
BULLISH ★ 5/10
$2.89 $3.10▲ +7.27%▲ +8.46%$1.51 (−47.75%)
Aug 13, 2026
11w ago
8-K
NEUTRAL ★ 4/10
No priceawaiting T+5awaiting T+5No price
Aug 13, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$2.71 $3.19▲ +17.71%▲ +19.68%$1.51 (−44.28%)
Jun 11, 2026
20w ago
Institutional Cluster
NEUTRAL ★ 5/10
$3.01 $2.84▼ −5.65%▼ −6.32%$1.51 (−49.83%)
Jun 3, 2026
21w ago
8-K
BULLISH ★ 7/10
$3.58 $3.04▼ −15.08%▼ −11.26%$1.51 (−57.82%)
Jun 1, 2026
21w ago
DEFA14A
NEUTRAL ★ 3/10
$3.67 $3.25▼ −11.44%▼ −8.69%$1.51 (−58.86%)
May 14, 2026
24w ago
8-K
BEARISH ★ 6/10
No priceawaiting T+5awaiting T+5No price
Showing 10 of 19

US Market Status

Market Closed · Opens Mon (20h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026